{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:00:07Z","timestamp":1790118007129,"version":"4.0.1"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.phymed.2026.158053","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:49:30Z","timestamp":1773074970000},"page":"158053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A review of plant-derived products regulating amyloid beta-degrading enzymes in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"155","author":[{"given":"Benyamin","family":"Honaramouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Imenshahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-851X","authenticated-orcid":false,"given":"Hossein","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158053_bib0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajcnut.2024.01.011","article-title":"A low dose of daily licorice intake affects renin, aldosterone, and home blood pressure in a randomized crossover trial","volume":"119","author":"Af Geijerstam","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2011-101716","article-title":"Decreased proteolytic activity of the mitochondrial amyloid-\u03b2 degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria","volume":"27","author":"Alikhani","year":"2011","journal-title":"J. Alzheimers. Dis."},{"issue":"9","key":"10.1016\/j.phymed.2026.158053_bib0003","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/ph15091074","article-title":"Alzheimer\u2019s disease severity is associated with an imbalance in serum levels of enzymes regulating plasmin synthesis","volume":"15","author":"Angelucci","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.phymed.2026.158053_bib0004","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF02118312","article-title":"Deficiency of fibrinolytic enzyme activities in the serum of patients with Alzheimer-type dementia","volume":"48","author":"Aoyagi","year":"1992","journal-title":"Experientia"},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0005","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1471-4159.1982.tb07930.x","article-title":"Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas","volume":"38","author":"Arregui","year":"1982","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0006","first-page":"60","article-title":"Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain","volume":"20","author":"Asahina","year":"2001","journal-title":"Clin. Neuropathol."},{"issue":"24","key":"10.1016\/j.phymed.2026.158053_bib0007","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1523\/JNEUROSCI.16-24-07910.1996","article-title":"Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40)","volume":"16","author":"Backstrom","year":"1996","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/mp.2008.96","article-title":"Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests","volume":"14","author":"Bates","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"47","key":"10.1016\/j.phymed.2026.158053_bib0009","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phymed.2026.158053_bib0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/NEN.0b013e3181c22569","article-title":"Increased matrix metalloproteinase 9 activity in mild cognitive impairment","volume":"68","author":"Bruno","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0011","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JAD-2010-1206","article-title":"Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease","volume":"19","author":"Bulloj","year":"2010","journal-title":"J. Alzheimers. Dis."},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0012","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","article-title":"Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders","volume":"26","author":"Caccamo","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3233\/JAD-190560","article-title":"Spatially distributed amyloid-\u03b2 reduces glucose metabolism in mild cognitive impairment","volume":"73","author":"Carbonell","year":"2020","journal-title":"J. Alzheimers. Dis."},{"issue":"10","key":"10.1016\/j.phymed.2026.158053_bib0014","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnen\/61.10.849","article-title":"Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy","volume":"61","author":"Carpentier","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"18","key":"10.1016\/j.phymed.2026.158053_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202100380","article-title":"Flavan-3-ol microbial metabolites modulate proteolysis in neuronal cells reducing amyloid-beta (1-42) levels","volume":"65","author":"Cecarini","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phymed.2026.158053_bib0016","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.joim.2021.09.006","article-title":"Angiotensin-converting enzyme inhibitors from plants: a review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications","volume":"19","author":"Chakraborty","year":"2021","journal-title":"J. Integr. Med."},{"issue":"29760","key":"10.1016\/j.phymed.2026.158053_bib0017","article-title":"Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer's disease","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phymed.2026.158053_bib0019","article-title":"Triptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer's disease","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS. One"},{"issue":"8","key":"10.1016\/j.phymed.2026.158053_bib0018","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2174\/1567205014666170207093455","article-title":"Vitamin D combined with resveratrol prevents cognitive decline in SAMP8 mice","volume":"14","author":"Cheng","year":"2017","journal-title":"Curr. Alzheimer. Res."},{"issue":"Pt 2","key":"10.1016\/j.phymed.2026.158053_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/bj3510509","article-title":"Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization","volume":"351","author":"Chesneau","year":"2000","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular. Med."},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0023","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jmb.2008.11.025","article-title":"Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity","volume":"385","author":"Ciaccio","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0024","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/1871527322666230510103540","article-title":"The effects and mechanism of Scutellaria baicalensis Georgi stems and leaves flavonoids on myelin sheath degeneration induced by composite A\u03b2 in rats","volume":"23","author":"Congcong","year":"2024","journal-title":"CNS. Neurol. Disord. Drug Targets."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158053_bib0027","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2026.158053_bib0028","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","article-title":"RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier","volume":"35","author":"Deane","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0026","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS. Neurol. Disord. Drug Targets."},{"issue":"56\u201365","key":"10.1016\/j.phymed.2026.158053_bib0029","article-title":"Improving the inhibition of \u03b2-amyloid aggregation by withanolide and withanoside derivatives","volume":"173","author":"Dubey","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12640-020-00168-2","article-title":"Mechanisms of l-serine-mediated neuroprotection include selective activation of lysosomal cathepsins B and L","volume":"39","author":"Dunlop","year":"2021","journal-title":"Neurotox. Res."},{"issue":"16","key":"10.1016\/j.phymed.2026.158053_bib0032","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1074\/jbc.M111571200","article-title":"Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD)","volume":"277","author":"Edbauer","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6006","key":"10.1016\/j.phymed.2026.158053_bib0034","first-page":"980","article-title":"Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science (1979)"},{"issue":"31","key":"10.1016\/j.phymed.2026.158053_bib0033","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1523\/JNEUROSCI.1608-14.2014","article-title":"Multiple factors contribute to the peripheral induction of cerebral \u03b2-amyloidosis","volume":"34","author":"Eisele","year":"2014","journal-title":"J. Neurosci."},{"issue":"107\u2013118","key":"10.1016\/j.phymed.2026.158053_bib0035","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-08927-0_12","article-title":"Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease","volume":"822","author":"El-Sayed","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0036","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/npp.2015.279","article-title":"Tissue-plasminogen activator attenuates Alzheimer's disease-related pathology development in APPswe\/PS1 mice","volume":"41","author":"ElAli","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.phymed.2026.158053_bib0037","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12307-016-0189-y","article-title":"Neuropeptide levels as well as neprilysin activity decrease in renal cell carcinoma","volume":"9","author":"Erin","year":"2016","journal-title":"Cancer Microenviron."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0039","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1471-4159.2009.05894.x","article-title":"Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain","volume":"109","author":"Fabbro","year":"2009","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0038","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1471-4159.2011.07359.x","article-title":"Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model","volume":"118","author":"Fabbro","year":"2011","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.phymed.2026.158053_bib0041","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"17","key":"10.1016\/j.phymed.2026.158053_bib0040","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1021\/bi0476578","article-title":"Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein","volume":"44","author":"Farris","year":"2005","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0042","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjpo.bp.116.004184","article-title":"Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease","volume":"3","author":"Fazal","year":"2017","journal-title":"BJPsych. Open."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0043","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/156720511794604561","article-title":"Transgenic mice as a model of pre-clinical Alzheimer's disease","volume":"8","author":"Ferretti","year":"2011","journal-title":"Curr. Alzheimer. Res."},{"issue":"11","key":"10.1016\/j.phymed.2026.158053_bib0044","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1134\/S0006297919110105","article-title":"Neutral endopeptidase (Neprilysin) in therapy and diagnostics: yin and Yang","volume":"84","author":"Feygina","year":"2019","journal-title":"Biochemistry. (Mosc)"},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0046","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jnr.21944","article-title":"Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease","volume":"87","author":"Guan","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"102\u2013111","key":"10.1016\/j.phymed.2026.158053_bib0047","article-title":"Plasminogen decreases A\u03b242 and tau deposition, and shows multi-beneficial effects on Alzheimer's disease in mice and humans","volume":"654","author":"Guo","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"102\u2013111","key":"10.1016\/j.phymed.2026.158053_bib0048","article-title":"Plasminogen decreases A\u03b242 and tau deposition, and shows multi-beneficial effects on Alzheimer's disease in mice and humans","volume":"654","author":"Guo","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0049","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajpath.2010.11.012","article-title":"Neprilysin-2 is an important \u03b2-amyloid degrading enzyme","volume":"178","author":"Hafez","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1533317507309803","article-title":"Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study","volume":"23","author":"Hajjar","year":"2008","journal-title":"Am. J. Alzheimers. Dis. Other Demen."},{"issue":"1835","key":"10.1016\/j.phymed.2026.158053_bib0051","article-title":"Palmatine improves cognitive dysfunction in Alzheimer's disease model rats through autophagy pathway and regulation of gut microbiota","volume":"15","author":"Han","year":"2024","journal-title":"Brain Res."},{"issue":"14","key":"10.1016\/j.phymed.2026.158053_bib0053","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/sj.gt.3302719","article-title":"Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo","volume":"13","author":"Hong","year":"2006","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0054","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of Solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.phymed.2026.158053_bib0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1515\/bc.2010.110","article-title":"Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease","volume":"391","author":"Hook","year":"2010","journal-title":"Biol. Chem."},{"issue":"13","key":"10.1016\/j.phymed.2026.158053_bib0056","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1074\/jbc.M603494200","article-title":"Inhibition of familial cerebral amyloid angiopathy mutant amyloid beta-protein fibril assembly by myelin basic protein","volume":"282","author":"Hoos","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.phymed.2026.158053_bib0057","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/bi900037s","article-title":"Myelin basic protein binds to and inhibits the fibrillar assembly of Abeta42 in vitro","volume":"48","author":"Hoos","year":"2009","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.phymed.2026.158053_bib0058","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1248\/bpb.b22-00833","article-title":"Enhancement of neprilysin activity by natural polyphenolic compounds and their derivatives in cultured neuroglioma cells","volume":"46","author":"Hori","year":"2023","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(99)00827-7","article-title":"Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population","volume":"277","author":"Hu","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"51","key":"10.1016\/j.phymed.2026.158053_bib0059","doi-asserted-by":"crossref","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity","volume":"276","author":"Hu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"147","key":"10.1016\/j.phymed.2026.158053_bib0062","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0064","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/72237","article-title":"Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat. Med."},{"issue":"5521","key":"10.1016\/j.phymed.2026.158053_bib0063","first-page":"1550","article-title":"Metabolic regulation of brain abeta by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science (1979)"},{"issue":"25","key":"10.1016\/j.phymed.2026.158053_bib0065","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0066","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1386207320666170130144443","article-title":"Machine learning and molecular dynamics based insights into mode of actions of insulin degrading enzyme modulators","volume":"20","author":"Jamal","year":"2017","journal-title":"Comb. Chem. High. Throughput. Screen."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0067","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3892\/ijmm.2011.615","article-title":"Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black tea","volume":"27","author":"Jankun","year":"2011","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0068","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ptr.3033","article-title":"Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease","volume":"24","author":"Jayaprakasam","year":"2010","journal-title":"PhytOther Res."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0069","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/mmr.2014.2254","article-title":"Tanshinone IIA reduces the risk of Alzheimer's disease by inhibiting iNOS, MMP\u20112 and NF\u2011\u03baBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease","volume":"10","author":"Jiang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.phymed.2026.158053_bib0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ng.2007.23","article-title":"Cystatin C modulates cerebral beta-amyloidosis","volume":"39","author":"Kaeser","year":"2007","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.phymed.2026.158053_bib0071","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12855","article-title":"4,5-dicaffeyolquinic acid improves high-fat diet-induced cognitive dysfunction through the regulation of insulin degrading enzyme","volume":"43","author":"Kang","year":"2019","journal-title":"J. Food Biochem."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0072","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/5009","article-title":"Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease","volume":"21","author":"Kehoe","year":"1999","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.phymed.2026.158053_bib0073","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1096\/fj.09-148825","article-title":"Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain","volume":"24","author":"Kim","year":"2010","journal-title":"FASEB J."},{"issue":"254\u2013260","key":"10.1016\/j.phymed.2026.158053_bib0074","article-title":"The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction","volume":"70","author":"Klein","year":"2013","journal-title":"Neuropharmacology."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0076","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)00387-4","article-title":"Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme","volume":"345","author":"Kurochkin","year":"1994","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0077","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/embo-reports\/kvd107","article-title":"Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains","volume":"1","author":"Ledesma","year":"2000","journal-title":"EMBo Rep."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0078","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.phymed.2026.158053_bib0079","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11655-011-0896-7","article-title":"Scavenging effect of Naoerkang on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer's disease","volume":"17","author":"Li","year":"2011","journal-title":"Chin. J. Integr. Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.158053_bib0082","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/1871527314666150225141521","article-title":"Protective effect of notoginsenoside R1 on an APP\/PS1 mouse model of Alzheimer's Disease by up-regulating insulin degrading enzyme and inhibiting A\u03b2 accumulation","volume":"14","author":"Li","year":"2015","journal-title":"CNS. Neurol. Disord. Drug Targets."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0081","doi-asserted-by":"crossref","first-page":"136","DOI":"10.31083\/j.fbl2904136","article-title":"Interactions between beta-amyloid and pericytes in Alzheimer's disease","volume":"29","author":"Li","year":"2024","journal-title":"Front. Biosci. (Landmark. Ed)"},{"issue":"42","key":"10.1016\/j.phymed.2026.158053_bib0083","doi-asserted-by":"crossref","first-page":"28917","DOI":"10.1074\/jbc.M109.050856","article-title":"Degradation of amyloid beta protein by purified myelin basic protein","volume":"284","author":"Liao","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0086","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2010.05.014","article-title":"Circulating neprilysin clears brain amyloid","volume":"45","author":"Liu","year":"2010","journal-title":"Mol. Cell Neurosci."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0087","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2010.05.014","article-title":"Circulating neprilysin clears brain amyloid","volume":"45","author":"Liu","year":"2010","journal-title":"Molecular Cellular Neurosci."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2009.06.003","article-title":"Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease","volume":"32","author":"Liu","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0088","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-2011-111472","article-title":"Characterization of insulin degrading enzyme and other amyloid-\u03b2 degrading proteases in human serum: a role in Alzheimer's disease?","volume":"29","author":"Liu","year":"2012","journal-title":"J. Alzheimers. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0089","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/jnc.15762","article-title":"Experimental approaches for altering the expression of Abeta-degrading enzymes","volume":"164","author":"Loeffler","year":"2023","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.phymed.2026.158053_bib0090","first-page":"890","article-title":"Effect of ginsenoside Rg1 on the influence of neprilysin expression induced by LPS in BT325 cell line]","volume":"29","author":"Luo","year":"2004","journal-title":"Zhongguo Zhong. Yao Za Zhi."},{"issue":"1355","key":"10.1016\/j.phymed.2026.158053_bib0091","article-title":"Therapeutic effects of natural drugs on Alzheimer's disease","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158053_bib0092","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3233\/JAD-2010-101197","article-title":"Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-\u03b242 levels in lewy body disease","volume":"22","author":"Maetzler","year":"2010","journal-title":"J. Alzheimers. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0093","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1523\/JNEUROSCI.23-06-01992.2003","article-title":"Neprilysin gene transfer reduces human amyloid pathology in transgenic mice","volume":"23","author":"Marr","year":"2003","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0094","first-page":"787","article-title":"Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines","volume":"7","author":"Melino","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.phymed.2026.158053_bib0095","doi-asserted-by":"crossref","unstructured":"Mett, J., Lauer, A.A., Janitschke, D., Griebsch, L.V., Theiss, E.L., Grimm, H.S., Koivisto, H., Tanila, H., Hartmann, T., Grimm, M.O.W., 2021. Medium-Chain Length Fatty Acids Enhance A\u03b2 Degradation by Affecting Insulin-Degrading Enzyme. Cells 10(11).","DOI":"10.3390\/cells10112941"},{"issue":"10","key":"10.1016\/j.phymed.2026.158053_bib0096","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","article-title":"Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"11","key":"10.1016\/j.phymed.2026.158053_bib0097","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/NEN.0b013e3182345e46","article-title":"A\u03b2-degrading enzymes: potential for treatment of Alzheimer disease","volume":"70","author":"Miners","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"38","key":"10.1016\/j.phymed.2026.158053_bib0098","doi-asserted-by":"crossref","first-page":"35460","DOI":"10.1074\/jbc.M202899200","article-title":"Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo","volume":"277","author":"Mohajeri","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phymed.2026.158053_bib0099","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2005.05.020","article-title":"Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia","volume":"332","author":"Morelli","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease","volume":"51","author":"Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0101","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1523\/JNEUROSCI.20-05-02003.2000","article-title":"Laminin degradation by plasmin regulates long-term potentiation","volume":"20","author":"Nakagami","year":"2000","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874609809666161111101111","article-title":"Role of ageing and oxidative stress in regulation of amyloid-degrading enzymes and development of neurodegeneration","volume":"10","author":"Nalivaeva","year":"2017","journal-title":"Curr. Aging Sci."},{"issue":"167\u2013185","key":"10.1016\/j.phymed.2026.158053_bib0102","article-title":"Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?","volume":"120","author":"Nalivaeva","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phymed.2026.158053_bib0103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnagi.2014.00235","article-title":"Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease","volume":"6","author":"Nalivaeva","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"92\u2013100","key":"10.1016\/j.phymed.2026.158053_bib0106","article-title":"The Ayurvedic plant bacopa monnieri inhibits inflammatory pathways in the brain","volume":"197","author":"Nemetchek","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158053_bib0107","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology."},{"issue":"73\u201379","key":"10.1016\/j.phymed.2026.158053_bib0108","article-title":"The ethanol extract of Zizyphus jujuba var. Spinosa seeds ameliorates the memory deficits in Alzheimer's disease model mice","volume":"233","author":"Park","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"114","key":"10.1016\/j.phymed.2026.158053_bib0109","article-title":"Deciphering the astrocyte reaction in Alzheimer's disease","volume":"10","author":"Perez-Nievas","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.phymed.2026.158053_bib0111","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.5b00190","article-title":"Oleocanthal enhances amyloid-\u03b2 clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model","volume":"18","author":"Qosa","year":"2015","journal-title":"ACS. Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.phymed.2026.158053_bib0112","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.phymed.2026.158053_bib0113","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1006\/bbrc.1994.2872","article-title":"Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A","volume":"205","author":"Roher","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.phymed.2026.158053_bib0114","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1073\/pnas.1112209109","article-title":"Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver","volume":"109","author":"Sehgal","year":"2012","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0116","first-page":"E657","article-title":"Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56)","volume":"273","author":"Shearer","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11064-011-0612-1","article-title":"The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3\u03b2 pathway mediates bilobalide-induced reduction in amyloid \u03b2-peptide","volume":"37","author":"Shi","year":"2012","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib162","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s11064-019-02756-x","article-title":"Powering amyloid beta degrading enzymes: a possible therapy for Alzheimer\u2019s disease","volume":"44","author":"Sikanyika","year":"2019","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0118","first-page":"45","article-title":"Theaflavin digallate inactivates plasminogen activator inhibitor: could tea help in Alzheimer's disease and obesity?","volume":"26","author":"Skrzypczak-Jankun","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0119","first-page":"10","article-title":"Cathepsin D: a candidate link between Amyloid \u03b2-protein and tauopathy in Alzheimer Disease","volume":"2","author":"Suire","year":"2021","journal-title":"J. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","article-title":"Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease","volume":"60","author":"Sun","year":"2008","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.phymed.2026.158053_bib0121","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2174\/1567205013666160615091043","article-title":"Serum insulin degrading enzyme level and other factors in type 2 diabetic patients with mild cognitive impairment","volume":"13","author":"Sun","year":"2016","journal-title":"Curr. Alzheimer. Res."},{"issue":"48","key":"10.1016\/j.phymed.2026.158053_bib0122","doi-asserted-by":"crossref","first-page":"37405","DOI":"10.1074\/jbc.M110.149468","article-title":"Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion","volume":"285","author":"Tamboli","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0123","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/cdd.2016.161","article-title":"Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against A\u03b2 toxicity in a mouse model of Alzheimer's disease","volume":"24","author":"Tao","year":"2017","journal-title":"Cell Death. Differ."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0124","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3233\/JAD-132192","article-title":"Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-\u03b2 in Alzheimer's disease","volume":"42","author":"Tian","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.phymed.2026.158053_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101999","article-title":"Insulin-degrading enzyme: roles and pathways in ameliorating cognitive impairment associated with Alzheimer's disease and diabetes","volume":"90","author":"Tian","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"408\u2013412","key":"10.1016\/j.phymed.2026.158053_bib0126","article-title":"Trans-crocetin improves amyloid-\u03b2 degradation in monocytes from Alzheimer's Disease patients","volume":"372","author":"Tiribuzi","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.phymed.2026.158053_bib0127","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1523\/JNEUROSCI.20-11-03937.2000","article-title":"The plasmin system is induced by and degrades amyloid-beta aggregates","volume":"20","author":"Tucker","year":"2000","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1515\/bchm3.1995.376.4.225","article-title":"Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and\/or endogenous protein inhibitors, cystatins","volume":"376","author":"Turk","year":"1995","journal-title":"Biol. Chem. Hoppe Seyler."},{"issue":"111344","key":"10.1016\/j.phymed.2026.158053_bib0129","article-title":"The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system","volume":"150","author":"Tzekaki","year":"2021","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5607\/en23014","article-title":"Advances in amyloid-\u03b2 clearance in the brain and periphery: implications for neurodegenerative diseases","volume":"32","author":"Ullah","year":"2023","journal-title":"Exp. Neurobiol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0131","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.phymed.2026.158053_bib0132","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/eurheartj\/ehv015","article-title":"Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split?","volume":"36","author":"Vodovar","year":"2015","journal-title":"Eur. Heart. J."},{"issue":"37","key":"10.1016\/j.phymed.2026.158053_bib161","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.476689","article-title":"COPS5 (Jab1) protein increases \u03b2 site processing of amyloid precursor protein and amyloid \u03b2 peptide generation by stabilizing RanBP9 protein levels","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phymed.2026.158053_bib0134","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4103\/1673-5374.205107","article-title":"Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation","volume":"12","author":"Wang","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"3862342","key":"10.1016\/j.phymed.2026.158053_bib0133","article-title":"Kai-Xin-San, a Chinese herbal decoction, accelerates the degradation of \u03b2-amyloid by enhancing the expression of neprilysin in rats","author":"Wang","year":"2020","journal-title":"Evid. Based. Complement. Alternat. Med."},{"issue":"11","key":"10.1016\/j.phymed.2026.158053_bib0136","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1080\/15548627.2021.1872187","article-title":"Crocetin promotes clearance of amyloid-\u03b2 by inducing autophagy via the STK11\/LKB1-mediated AMPK pathway","volume":"17","author":"Wani","year":"2021","journal-title":"Autophagy."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0137","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamaneurol.2019.3988","article-title":"Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials","volume":"77","author":"Wessels","year":"2020","journal-title":"JAMa Neurol."},{"issue":"16","key":"10.1016\/j.phymed.2026.158053_bib0138","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.febslet.2008.05.046","article-title":"Human neprilysin-2 (NEP2) and NEP display distinct subcellular localisations and substrate preferences","volume":"582","author":"Whyteside","year":"2008","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.phymed.2026.158053_bib0140","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1039\/D0FO00161A","article-title":"Up-regulation of neprilysin mediates the protection of fructo-oligosaccharides against Alzheimer's disease","volume":"11","author":"Wu","year":"2020","journal-title":"Food Funct."},{"issue":"34","key":"10.1016\/j.phymed.2026.158053_bib0143","doi-asserted-by":"crossref","first-page":"24566","DOI":"10.1074\/jbc.M602440200","article-title":"Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ","volume":"281","author":"Yan","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3295\u20133323","key":"10.1016\/j.phymed.2026.158053_bib0142","article-title":"The role of traditional Chinese medicine natural products in \u03b2-amyloid deposition and tau protein hyperphosphorylation in Alzheimer's disease","volume":"17","author":"Yan","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"issue":"13","key":"10.1016\/j.phymed.2026.158053_bib0144","article-title":"Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs","volume":"5","author":"Yan","year":"2016","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.phymed.2026.158053_bib0146","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1211\/jpp.61.03.0013","article-title":"Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin","volume":"61","author":"Yang","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158053_bib0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2011.01.005","article-title":"Mechanism mediating oligomeric A\u03b2 clearance by na\u00efve primary microglia","volume":"42","author":"Yang","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"43","key":"10.1016\/j.phymed.2026.158053_bib0147","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","article-title":"Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism","volume":"26","author":"Yin","year":"2006","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0148","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/PL00007428","article-title":"Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain","volume":"99","author":"Yoshiyama","year":"2000","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0149","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3736\/jcim20100210","article-title":"Effects of Naoerkang on expressions of beta-amyloid peptide 1-42 and neprilysin in hippocampus in a rat model of Alzheimer's disease]","volume":"8","author":"Yuan","year":"2010","journal-title":"Zhong. Xi. Yi. Jie He Xue Bao"},{"issue":"5","key":"10.1016\/j.phymed.2026.158053_bib0150","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.20151428","article-title":"Rapid in vivo measurement of \u03b2-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model","volume":"213","author":"Yuede","year":"2016","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0151","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/tnsci-2020-0178","article-title":"Tripchlorolide attenuates \u03b2-amyloid generation by inducing NEP activity in N2a\/APP695 cells","volume":"12","author":"Zeng","year":"2021","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.phymed.2026.158053_bib0153","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2017.07.060","article-title":"Meta-analysis of expression and function of neprilysin in Alzheimer's disease","volume":"657","author":"Zhang","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.phymed.2026.158053_bib0152","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/rej.2018.2080","article-title":"Postsynaptic GluR2 involved in amelioration of A\u03b2-induced memory dysfunction by KAIXIN-San through rescuing hippocampal LTP in mice","volume":"22","author":"Zhang","year":"2019","journal-title":"Rejuvenation. Res."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0156","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neurobiolaging.2006.05.001","article-title":"Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease","volume":"28","author":"Zhao","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phymed.2026.158053_bib0154","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-4-4","article-title":"Insulin-degrading enzyme is exported via an unconventional protein secretion pathway","volume":"4","author":"Zhao","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phymed.2026.158053_bib0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.31083\/j.jin2201002","article-title":"A review of the pathogenesis and Chinese medicine intervention of Alzheimer's disease","volume":"22","author":"Zhao","year":"2022","journal-title":"J. Integr. Neurosci."},{"issue":"1140945","key":"10.1016\/j.phymed.2026.158053_bib0157","article-title":"Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome via network pharmacology and molecular docking analysis","volume":"13","author":"Zheng","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158053_bib0158","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s11064-019-02796-3","article-title":"Regulation of neprilysin activity and cognitive functions in rats after prenatal hypoxia","volume":"44","author":"Zhuravin","year":"2019","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158053_bib0159","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/jpet.105.095687","article-title":"Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid beta and impairment of learning and memory","volume":"317","author":"Zou","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"14","key":"10.1016\/j.phymed.2026.158053_bib0160","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1111\/febs.16939","article-title":"Molecular basis of selective amyloid-\u03b2 degrading enzymes in Alzheimer's disease","volume":"291","author":"\u017bukowska","year":"2024","journal-title":"FEBS. J."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:59:08Z","timestamp":1790114348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326002898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":149,"alternative-id":["S0944711326002898"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158053","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of plant-derived products regulating amyloid beta-degrading enzymes in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158053"}}